首页|参附注射液联合常规西药治疗冠心病伴急性心力衰竭患者的效果

参附注射液联合常规西药治疗冠心病伴急性心力衰竭患者的效果

扫码查看
目的:观察参附注射液联合常规西药治疗冠心病伴急性心力衰竭患者的效果.方法:选取 2021 年 3 月至 2023 年 2 月该院收治的 72 例冠心病伴急性心力衰竭患者进行前瞻性研究,按照随机数字表法分为研究组与对照组各 36 例.对照组采用常规西药治疗,研究组在对照组基础上联合参附注射液治疗,比较两组治疗总有效率,心功能指标[左心室射血分数(LVEF)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)]、心肌纤维化指标[IV型胶原(C-IV)、层粘连蛋白(LN)、透明质酸(HA)]、心肌损伤标志物[内皮素-1(ET-1)、肌钙蛋白Ⅰ(cTnⅠ)、N-末端脑钠肽前体(NT-proBNP)]、心肌酶谱[肌酸激酶同工酶(CK-MB)、肌酸激酶(CK)]水平,以及治疗期间不良反应发生率.结果:研究组治疗总有效率为 86.11%,明显高于对照组的 63.89%,差异有统计学意义(P<0.05);治疗后,两组LVEF水平高于治疗前,且研究组高于对照组,两组LVESD、LVEDD、C-IV、LN、HA、cTnⅠ、NT-proBNP、ET-1、CK-MB、CK水平低于治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05);治疗期间,两组均未出现明显不良反应.结论:参附注射液联合常规西药治疗冠心病伴急性心力衰竭患者可提高治疗总有效率,改善心功能指标水平,降低心肌纤维化指标、心肌损伤标志物、心肌酶谱水平,效果优于单纯常规西药治疗.
Effects of Shenfu injection combined with conventional Western medicine in treatment of patients with coronary heart disease and acute heart failure
Objective:To observe effects of Shenfu injection combined with conventional Western medicine in treatment of patients with coronary heart disease and acute heart failure.Methods:A prospective study was conducted on 72 patients with coronary heart disease and acute heart failure admitted to the hospital from March 2021 to February 2023.According to the random number table method,they were divided into study group and control group,36 cases in each group.The control group was treated with conventional Western medicine,while the study group was treated with Shenfu injection on the basis of that of the control group.The total effective rate of treatment,the levels of cardiac function indexes[left ventricular ejection fraction(LVEF),left ventricular end systolic diameter(LVESD),left ventricular end diastolic diameter(LVEDD)],the myocardial fibrosis indexes[type IV collagen(C-IV),laminin(LN),hyaluronic acid(HA)],the myocardial injury markers[endothelin-1(ET-1),troponinI(cTnⅠ),amino terminal pro brain natriuretic peptide(NT-proBNP)],and the myocardial enzymes[creatine kinase isoenzyme(CK-MB),creatine kinase(CK)],and the incidence of adverse reactions during treatment were compared between the two groups.Results:The total effective rate of the study group was 86.11%,which was significantly higher than 63.89%of the control group,and the difference was statistically significant(P<0.05).After the treatment,the LVEF levels of the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;the levels of LVESD,LVEDD,C-IV,LN,HA,cTnⅠ,NT-proBNP,ET-1,CK-MB and CK in the two groups were lower than those before treatment,and those in the study group were lower than those in the control group;and the differences were statistically significant(P<0.05).During the treatment,there were no obvious adverse reactions in the two groups.Conclusions:Shenfu injection combined with conventional Western medicine in the treatment of the patients with coronary heart disease and acute heart failure can improve the total effective rate of treatment,improve the levels of cardiac function indexes,and reduce the levels of myocardial fibrosis indexes,myocardial injury markers and myocardial enzymes.Moreover,it is superior to simple conventional Western medicine treatment.

Shenfu injectionCoronary heart diseaseAcute heart failureMyocardial enzyme spectrumCardiac functionMyocardial injuryMyocardial fibrosis

赵山林、徐晶

展开 >

平顶山市第一人民医院药剂科,河南 平顶山 467000

参附注射液 冠心病 急性心力衰竭 心肌酶谱 心功能 心肌损伤 心肌纤维化

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(17)